Role of advanced glycation end products and insulin resistance in diabetic nephropathy

被引:45
|
作者
Parwani, Kirti [1 ]
Mandal, Palash [1 ]
机构
[1] Charotar Univ Sci & Technol, PD Patel Inst Appl Sci, Dept Biol Sci, Changa 388421, Gujarat, India
关键词
Advanced glycation end products; insulin resistance; receptor for advanced glycation end products; endoplasmic reticulum stress; diabetic nephropathy; ENDOPLASMIC-RETICULUM STRESS; INDUCED PODOCYTE APOPTOSIS; UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; URSODEOXYCHOLIC ACID; DOWN-REGULATION; ELEVATED LEVELS; RECEPTOR;
D O I
10.1080/13813455.2020.1797106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic syndrome (MetS), i.e. a cluster of physiological and biochemical abnormalities can lead to diabetic nephropathy (DN). Insulin resistance, impaired fasting glucose are the main signs and symptoms of MetS. Excess sugar can induce various substantial structural changes like formation of advanced glycation end products (AGEs). AGEs are formed due to reaction of reducing sugars with amino groups of proteins, lipids and nucleic acids. AGEs when bound to the receptor for advanced glycation end products (RAGE) activate increased production of pro-inflammatory markers like interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-alpha) along with induction of endoplasmic reticulum (ER) stress. Accumulation of AGEs, enhanced reactive oxygen species (ROS) generation and activation of protein kinase C (PKC), are considered to induce glomerular hypertrophy, podocyte apoptosis, therefore contributing to the development and progression of DN. In this review, we decipher different biochemical and physiological factors that link AGEs and DN.
引用
收藏
页码:95 / 107
页数:13
相关论文
共 50 条
  • [21] Advanced glycation end products: role in pathology of diabetic cardiomyopathy
    Vijaya Lakshmi Bodiga
    Sasidhar Reddy Eda
    Sreedhar Bodiga
    Heart Failure Reviews, 2014, 19 : 49 - 63
  • [22] Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
    Bolton, WK
    Cattran, DC
    Williams, ME
    Adler, SG
    Appel, GB
    Cartwright, K
    Foiles, PG
    Freedman, BI
    Raskin, P
    Ratner, RE
    Spinowitz, BS
    Whittier, FC
    Wuerth, JP
    AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) : 32 - 40
  • [23] Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: Role of advanced glycation end products
    Lassila, M
    Seah, KK
    Allen, TJ
    Thallas, V
    Thomas, MC
    Candido, R
    Burns, WC
    Forbes, JM
    Calkin, AC
    Cooper, ME
    Jandeleit-Dahm, KAM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 2125 - 2138
  • [24] Serum advanced glycation end products (AGEs) are associated with insulin resistance
    Tan, Kathryn C. B.
    Shiu, Sammy W. M.
    Wong, Ying
    Tam, Xystus
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (05) : 488 - 492
  • [25] Pathogenic role of advanced glycosylation end products in diabetic nephropathy
    Lee, HB
    Cha, MK
    Song, KI
    Kim, JH
    Lee, EY
    Kim, SI
    Kim, J
    Yoo, MH
    KIDNEY INTERNATIONAL, 1997, : S60 - S65
  • [26] Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats
    Zabad, Imad Eddin M.
    Amin, Mohamed N.
    El-Shishtawy, Mamdouh M.
    LIFE SCIENCES, 2019, 239
  • [27] Dietary Advanced Glycation End Products in an Elderly Population with Diabetic Nephropathy: An Exploratory Investigation
    Steenbeke, Mieke
    De Decker, Ignace
    Marchand, Sophie
    Glorieux, Griet
    Van Biesen, Wim
    Lapauw, Bruno
    Delanghe, Joris R.
    Speeckaert, Marijn M.
    NUTRIENTS, 2022, 14 (09)
  • [28] Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy
    Forbes, JM
    Cooper, ME
    Thallas, V
    Burns, WC
    Thomas, MC
    Brammar, GC
    Lee, F
    Grant, SL
    Burrell, LA
    Jerums, G
    Osicka, TM
    DIABETES, 2002, 51 (11) : 3274 - 3282
  • [29] Advanced glycation end products and diabetic retinopathy
    Ross Milne
    Seymour Brownstein
    Amino Acids, 2013, 44 : 1397 - 1407
  • [30] ADVANCED GLYCATION END PRODUCTS IN PROGRESSIVE COURSE OF DIABETIC NEPHROPATHY: EXPLORING INTERACTIVE ASSOCIATIONS
    Bharti, Augustin Kumar
    Agrawal, Amit
    Agrawal, Suraj
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2015, 6 (02): : 521 - 528